HyLabsProductsClinical DiagnosticPoint of careLumiraDx SARS-CoV-2 Ag Test

Product: LumiraDx SARS-CoV-2 Ag Test

Rapid results in minutes at the point of care

The LumiraDx SARS-CoV-2 Ag Test is a microfluidic immunofluorescence assay for direct and qualitative detection of nucleocapsid proteins in nasal swab specimens from patients suspected of COVID-19. Used with the LumiraDx Instrument the Test delivers rapid results at the point-of-care.

Test Benefits
The use of a LumiraDx SARS-CoV-2 Ag Test on the LumiraDx Instruments will enable the physician to verify infection quickly, begin proper treatment and to initiate isolation precautions helping prevent further spread of infection.

  • Easy to implement in point-of-care settings
  • Clinical performance
    97.6% positive percent agreement
    96.6% negative percent agreement
  • Analytical performance with a limit of detection of 32 TCID50/mL
  • RT-PCR comparable results within 12 days of onset of symptoms

Link to LumiraDx website

?Have questions ? need a price quote

Please contact us and we will get back to you shortly.


        [0] => 13
        [1] => 38
        [2] => 234
        [3] => 53